HEADER HYDROLASE/HYDROLASE INHIBITOR 29-MAY-12 4FEA TITLE CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ALLOSTERIC INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-7; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: P20/P10 CATALYTIC DOMAIN (UNP RESIDUES 57-303); COMPND 5 SYNONYM: CASP-7, APOPTOTIC PROTEASE MCH-3, CMH-1, ICE-LIKE APOPTOTIC COMPND 6 PROTEASE 3, ICE-LAP3; COMPND 7 EC: 3.4.22.60; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP7, MCH3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CYSTEINE PROTEASE, APOPTOSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR V.KABALEESWARAN REVDAT 3 13-SEP-23 4FEA 1 REMARK REVDAT 2 12-SEP-12 4FEA 1 JRNL REVDAT 1 01-AUG-12 4FEA 0 JRNL AUTH T.FELDMAN,V.KABALEESWARAN,S.B.JANG,C.ANTCZAK,H.DJABALLAH, JRNL AUTH 2 H.WU,X.JIANG JRNL TITL A CLASS OF ALLOSTERIC CASPASE INHIBITORS IDENTIFIED BY JRNL TITL 2 HIGH-THROUGHPUT SCREENING. JRNL REF MOL.CELL V. 47 585 2012 JRNL REFN ISSN 1097-2765 JRNL PMID 22795132 JRNL DOI 10.1016/J.MOLCEL.2012.06.007 REMARK 2 REMARK 2 RESOLUTION. 3.79 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.79 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 76.83 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 92.5 REMARK 3 NUMBER OF REFLECTIONS : 8257 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.242 REMARK 3 R VALUE (WORKING SET) : 0.236 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.640 REMARK 3 FREE R VALUE TEST SET COUNT : 383 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 76.8496 - 5.4587 0.90 2657 121 0.2538 0.2741 REMARK 3 2 5.4587 - 4.3329 0.93 2588 140 0.2131 0.2916 REMARK 3 3 4.3329 - 3.7900 0.94 2629 122 0.2380 0.2840 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.86 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 111.5 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.050 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 120.6 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 15.88900 REMARK 3 B22 (A**2) : 15.88900 REMARK 3 B33 (A**2) : -31.77790 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 2842 REMARK 3 ANGLE : 1.352 3839 REMARK 3 CHIRALITY : 0.054 449 REMARK 3 PLANARITY : 0.003 485 REMARK 3 DIHEDRAL : 14.330 991 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4FEA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUN-12. REMARK 100 THE DEPOSITION ID IS D_1000072792. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 23-ID-B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.378 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8266 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.785 REMARK 200 RESOLUTION RANGE LOW (A) : 76.834 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 200 DATA REDUNDANCY : 5.100 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10800 REMARK 200 FOR THE DATA SET : 11.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.79 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.88 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.70000 REMARK 200 R SYM FOR SHELL (I) : 0.70000 REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3IBF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 67.24 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CITRATE, PH 5.0-5.7, 1.9 REMARK 280 M SODIUM FORMATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 277K, PH 5.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 123.77333 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 61.88667 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 61.88667 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 123.77333 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 77 REMARK 465 PHE A 78 REMARK 465 ASP A 79 REMARK 465 LYS A 80 REMARK 465 VAL A 81 REMARK 465 THR A 82 REMARK 465 GLY A 83 REMARK 465 MET A 84 REMARK 465 GLY A 85 REMARK 465 VAL A 86 REMARK 465 ARG A 87 REMARK 465 ASN A 88 REMARK 465 GLY A 89 REMARK 465 THR A 90 REMARK 465 GLY A 145 REMARK 465 GLU A 146 REMARK 465 GLU A 147 REMARK 465 ASN A 148 REMARK 465 VAL A 149 REMARK 465 ILE A 150 REMARK 465 TYR A 151 REMARK 465 GLY A 152 REMARK 465 LYS A 153 REMARK 465 ASP A 154 REMARK 465 GLY A 155 REMARK 465 ARG A 187 REMARK 465 GLY A 188 REMARK 465 THR A 189 REMARK 465 GLU A 190 REMARK 465 LEU A 191 REMARK 465 ASP A 192 REMARK 465 ASP A 193 REMARK 465 GLY A 194 REMARK 465 ILE A 195 REMARK 465 GLN A 196 REMARK 465 ALA A 197 REMARK 465 ASP A 198 REMARK 465 SER A 199 REMARK 465 GLY A 200 REMARK 465 PRO A 201 REMARK 465 ILE A 202 REMARK 465 ASN A 203 REMARK 465 ASP A 204 REMARK 465 THR A 205 REMARK 465 ASP A 206 REMARK 465 ALA A 207 REMARK 465 ASN A 208 REMARK 465 PRO A 209 REMARK 465 ARG A 210 REMARK 465 TYR A 211 REMARK 465 LYS A 212 REMARK 465 ILE A 213 REMARK 465 PRO A 227 REMARK 465 GLY A 228 REMARK 465 TYR A 229 REMARK 465 TYR A 230 REMARK 465 SER A 231 REMARK 465 TRP A 232 REMARK 465 ARG A 233 REMARK 465 SER A 234 REMARK 465 PRO A 235 REMARK 465 GLY A 236 REMARK 465 PHE A 273 REMARK 465 GLU A 274 REMARK 465 SER A 275 REMARK 465 GLN A 276 REMARK 465 SER A 277 REMARK 465 ASP A 278 REMARK 465 ASP A 279 REMARK 465 PRO A 280 REMARK 465 HIS A 281 REMARK 465 PHE A 282 REMARK 465 HIS A 283 REMARK 465 GLU A 284 REMARK 465 LYS A 285 REMARK 465 LYS A 286 REMARK 465 GLN A 287 REMARK 465 ARG B 187 REMARK 465 GLY B 188 REMARK 465 THR B 189 REMARK 465 GLU B 190 REMARK 465 LEU B 191 REMARK 465 ASP B 192 REMARK 465 ASP B 193 REMARK 465 GLY B 194 REMARK 465 ILE B 195 REMARK 465 GLN B 196 REMARK 465 ALA B 197 REMARK 465 ASP B 198 REMARK 465 SER B 199 REMARK 465 GLY B 200 REMARK 465 PRO B 201 REMARK 465 ILE B 202 REMARK 465 ASN B 203 REMARK 465 ASP B 204 REMARK 465 THR B 205 REMARK 465 ASP B 206 REMARK 465 ALA B 207 REMARK 465 ASN B 208 REMARK 465 PRO B 209 REMARK 465 ARG B 210 REMARK 465 TYR B 211 REMARK 465 LYS B 212 REMARK 465 ILE B 213 REMARK 465 THR B 225 REMARK 465 VAL B 226 REMARK 465 PRO B 227 REMARK 465 GLY B 228 REMARK 465 TYR B 229 REMARK 465 TYR B 230 REMARK 465 SER B 231 REMARK 465 TRP B 232 REMARK 465 ARG B 233 REMARK 465 SER B 234 REMARK 465 GLU B 274 REMARK 465 SER B 275 REMARK 465 GLN B 276 REMARK 465 SER B 277 REMARK 465 ASP B 278 REMARK 465 ASP B 279 REMARK 465 PRO B 280 REMARK 465 HIS B 281 REMARK 465 PHE B 282 REMARK 465 HIS B 283 REMARK 465 GLU B 284 REMARK 465 LYS B 285 REMARK 465 LYS B 286 REMARK 465 GLN B 287 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 144 CG ND1 CD2 CE1 NE2 REMARK 470 LYS A 160 CG CD CE NZ REMARK 470 ARG A 167 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 170 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 172 CG CD CE NZ REMARK 470 GLU A 176 CG CD OE1 OE2 REMARK 470 LYS A 177 CG CD CE NZ REMARK 470 GLU A 216 CG CD OE1 OE2 REMARK 470 TYR A 223 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 237 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 254 CG CD CE NZ REMARK 470 ARG A 264 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 268 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 297 CG CD CE NZ REMARK 470 TYR A 300 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 80 CG CD CE NZ REMARK 470 LYS B 92 CG CD CE NZ REMARK 470 LYS B 118 CG CD CE NZ REMARK 470 LYS B 124 CG CD CE NZ REMARK 470 LYS B 125 CG CD CE NZ REMARK 470 GLU B 147 CG CD OE1 OE2 REMARK 470 LYS B 153 CG CD CE NZ REMARK 470 LYS B 160 CG CD CE NZ REMARK 470 ARG B 167 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 172 CG CD CE NZ REMARK 470 GLU B 216 CG CD OE1 OE2 REMARK 470 TYR B 223 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG B 237 CG CD NE CZ NH1 NH2 REMARK 470 GLN B 243 CG CD OE1 NE2 REMARK 470 GLU B 250 CG CD OE1 OE2 REMARK 470 LYS B 254 CG CD CE NZ REMARK 470 ARG B 271 CG CD NE CZ NH1 NH2 REMARK 470 PHE B 273 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS B 297 CG CD CE NZ REMARK 470 GLN B 303 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 289 C - N - CD ANGL. DEV. = -14.7 DEGREES REMARK 500 PRO B 289 C - N - CD ANGL. DEV. = -14.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 65 -86.30 -65.20 REMARK 500 LEU A 67 -71.29 -66.18 REMARK 500 CYS A 114 96.14 -64.33 REMARK 500 CYS A 116 -17.91 -39.28 REMARK 500 ARG A 167 -168.09 -65.83 REMARK 500 LEU A 174 69.52 -118.52 REMARK 500 GLU A 176 18.29 58.56 REMARK 500 ALA A 222 106.67 -168.32 REMARK 500 ASP A 255 20.83 -141.99 REMARK 500 CYS A 290 -172.51 -65.76 REMARK 500 VAL A 291 99.33 -163.91 REMARK 500 ASN B 63 77.12 -68.98 REMARK 500 LEU B 67 -72.33 -73.63 REMARK 500 CYS B 70 76.49 -154.80 REMARK 500 CYS B 136 -156.38 -124.92 REMARK 500 SER B 143 -161.83 -165.77 REMARK 500 GLU B 146 -149.89 -134.72 REMARK 500 CYS B 171 69.84 -153.24 REMARK 500 VAL B 215 -87.05 -62.04 REMARK 500 GLU B 216 33.25 -93.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0TE A 701 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0TE B 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4FDL RELATED DB: PDB DBREF 4FEA A 57 303 UNP P55210 CASP7_HUMAN 57 303 DBREF 4FEA B 57 303 UNP P55210 CASP7_HUMAN 57 303 SEQRES 1 A 247 THR TYR GLN TYR ASN MET ASN PHE GLU LYS LEU GLY LYS SEQRES 2 A 247 CYS ILE ILE ILE ASN ASN LYS ASN PHE ASP LYS VAL THR SEQRES 3 A 247 GLY MET GLY VAL ARG ASN GLY THR ASP LYS ASP ALA GLU SEQRES 4 A 247 ALA LEU PHE LYS CYS PHE ARG SER LEU GLY PHE ASP VAL SEQRES 5 A 247 ILE VAL TYR ASN ASP CYS SER CYS ALA LYS MET GLN ASP SEQRES 6 A 247 LEU LEU LYS LYS ALA SER GLU GLU ASP HIS THR ASN ALA SEQRES 7 A 247 ALA CYS PHE ALA CYS ILE LEU LEU SER HIS GLY GLU GLU SEQRES 8 A 247 ASN VAL ILE TYR GLY LYS ASP GLY VAL THR PRO ILE LYS SEQRES 9 A 247 ASP LEU THR ALA HIS PHE ARG GLY ASP ARG CYS LYS THR SEQRES 10 A 247 LEU LEU GLU LYS PRO LYS LEU PHE PHE ILE GLN ALA CYS SEQRES 11 A 247 ARG GLY THR GLU LEU ASP ASP GLY ILE GLN ALA ASP SER SEQRES 12 A 247 GLY PRO ILE ASN ASP THR ASP ALA ASN PRO ARG TYR LYS SEQRES 13 A 247 ILE PRO VAL GLU ALA ASP PHE LEU PHE ALA TYR SER THR SEQRES 14 A 247 VAL PRO GLY TYR TYR SER TRP ARG SER PRO GLY ARG GLY SEQRES 15 A 247 SER TRP PHE VAL GLN ALA LEU CYS SER ILE LEU GLU GLU SEQRES 16 A 247 HIS GLY LYS ASP LEU GLU ILE MET GLN ILE LEU THR ARG SEQRES 17 A 247 VAL ASN ASP ARG VAL ALA ARG HIS PHE GLU SER GLN SER SEQRES 18 A 247 ASP ASP PRO HIS PHE HIS GLU LYS LYS GLN ILE PRO CYS SEQRES 19 A 247 VAL VAL SER MET LEU THR LYS GLU LEU TYR PHE SER GLN SEQRES 1 B 247 THR TYR GLN TYR ASN MET ASN PHE GLU LYS LEU GLY LYS SEQRES 2 B 247 CYS ILE ILE ILE ASN ASN LYS ASN PHE ASP LYS VAL THR SEQRES 3 B 247 GLY MET GLY VAL ARG ASN GLY THR ASP LYS ASP ALA GLU SEQRES 4 B 247 ALA LEU PHE LYS CYS PHE ARG SER LEU GLY PHE ASP VAL SEQRES 5 B 247 ILE VAL TYR ASN ASP CYS SER CYS ALA LYS MET GLN ASP SEQRES 6 B 247 LEU LEU LYS LYS ALA SER GLU GLU ASP HIS THR ASN ALA SEQRES 7 B 247 ALA CYS PHE ALA CYS ILE LEU LEU SER HIS GLY GLU GLU SEQRES 8 B 247 ASN VAL ILE TYR GLY LYS ASP GLY VAL THR PRO ILE LYS SEQRES 9 B 247 ASP LEU THR ALA HIS PHE ARG GLY ASP ARG CYS LYS THR SEQRES 10 B 247 LEU LEU GLU LYS PRO LYS LEU PHE PHE ILE GLN ALA CYS SEQRES 11 B 247 ARG GLY THR GLU LEU ASP ASP GLY ILE GLN ALA ASP SER SEQRES 12 B 247 GLY PRO ILE ASN ASP THR ASP ALA ASN PRO ARG TYR LYS SEQRES 13 B 247 ILE PRO VAL GLU ALA ASP PHE LEU PHE ALA TYR SER THR SEQRES 14 B 247 VAL PRO GLY TYR TYR SER TRP ARG SER PRO GLY ARG GLY SEQRES 15 B 247 SER TRP PHE VAL GLN ALA LEU CYS SER ILE LEU GLU GLU SEQRES 16 B 247 HIS GLY LYS ASP LEU GLU ILE MET GLN ILE LEU THR ARG SEQRES 17 B 247 VAL ASN ASP ARG VAL ALA ARG HIS PHE GLU SER GLN SER SEQRES 18 B 247 ASP ASP PRO HIS PHE HIS GLU LYS LYS GLN ILE PRO CYS SEQRES 19 B 247 VAL VAL SER MET LEU THR LYS GLU LEU TYR PHE SER GLN HET 0TE A 701 21 HET 0TE B 701 21 HETNAM 0TE CHLORO{METHYL HYDROGENATO(3-)-KAPPA~2~N,S [PYRIDIN-2- HETNAM 2 0TE YL(PYRIDIN-2(1H)-YLIDENE-KAPPAN) HETNAM 3 0TE METHYL]CARBONODITHIOHYDRAZONATE}COPPER FORMUL 3 0TE 2(C13 H11 CL CU N4 S2) HELIX 1 1 LYS A 92 SER A 103 1 12 HELIX 2 2 CYS A 116 GLU A 128 1 13 HELIX 3 3 ILE A 159 ALA A 164 1 6 HELIX 4 4 HIS A 165 ARG A 167 5 3 HELIX 5 5 SER A 239 GLU A 250 1 12 HELIX 6 6 HIS A 252 LEU A 256 5 5 HELIX 7 7 GLU A 257 ARG A 271 1 15 HELIX 8 8 ASP B 79 GLY B 83 5 5 HELIX 9 9 GLY B 89 SER B 103 1 15 HELIX 10 10 SER B 115 GLU B 128 1 14 HELIX 11 11 ILE B 159 HIS B 165 1 7 HELIX 12 12 CYS B 171 LEU B 175 5 5 HELIX 13 13 SER B 239 GLY B 253 1 15 HELIX 14 14 GLU B 257 PHE B 273 1 17 SHEET 1 A12 ASP A 107 ASN A 112 0 SHEET 2 A12 LYS A 66 ASN A 74 1 N ASN A 74 O TYR A 111 SHEET 3 A12 ALA A 134 LEU A 142 1 O ILE A 140 N ILE A 73 SHEET 4 A12 LYS A 179 ALA A 185 1 O PHE A 182 N CYS A 139 SHEET 5 A12 PHE A 219 THR A 225 1 O ALA A 222 N ILE A 183 SHEET 6 A12 VAL A 292 MET A 294 -1 O MET A 294 N PHE A 219 SHEET 7 A12 CYS B 290 SER B 293 -1 O VAL B 291 N SER A 293 SHEET 8 A12 PHE B 219 SER B 224 -1 N PHE B 221 O VAL B 292 SHEET 9 A12 LYS B 179 ALA B 185 1 N ILE B 183 O SER B 224 SHEET 10 A12 ALA B 138 SER B 143 1 N LEU B 141 O PHE B 182 SHEET 11 A12 GLY B 68 ASN B 74 1 N ILE B 71 O ILE B 140 SHEET 12 A12 PHE B 106 ASN B 112 1 O TYR B 111 N ILE B 72 SHEET 1 B 3 GLY B 145 GLU B 146 0 SHEET 2 B 3 VAL B 149 TYR B 151 -1 O VAL B 149 N GLU B 146 SHEET 3 B 3 VAL B 156 PRO B 158 -1 O THR B 157 N ILE B 150 SITE 1 AC1 5 CYS A 290 GLU B 216 PHE B 221 MET B 294 SITE 2 AC1 5 0TE B 701 SITE 1 AC2 5 GLU A 216 VAL A 292 MET A 294 0TE A 701 SITE 2 AC2 5 CYS B 290 CRYST1 88.720 88.720 185.660 90.00 90.00 120.00 P 32 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011271 0.006508 0.000000 0.00000 SCALE2 0.000000 0.013015 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005386 0.00000